Skip to Content

MELPHALAN 2 MG TABLETS

Active substance(s): MELPHALAN / MELPHALAN / MELPHALAN

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

ASPEN Artwork Panel
7000183-1001

AW Version:
1

Package Leaflet: Information for the User

New Item Code:
7000183-1001

Melphalan 2mg tablets

Replacement:
7212466-6758

melphalan

Market:
United Kingdom

Read all of this leaflet carefully before you start taking this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions about your illness or your medicine, ask your
doctor, nurse or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may
harm them, even if their symptoms are the same as yours.
• If any of the side effects get serious, or if you notice any side effects not listed in
this leaflet, please tell your doctor, nurse or pharmacist.

Number of Colours:
1
BLACK

Manufacturing Site:
Excella
Drawing Ref. Number:
148 x 630 folded Plano V02

Originated by:
Alanna Clinton

Melphalan tablets contain a medicine called melphalan. This belongs to a group of
medicines called cytotoxics (also called chemotherapy). Melphalan is used to treat
cancer. It works by reducing the number of abnormal cells your body makes.

Originated at:
APTL

Melphalan is used for:
• Multiple myeloma - a type of cancer that develops from cells in the bone
marrow called plasma cells. Plasma cells help to fight infection and disease by
producing antibodies
• Advanced cancer of the ovaries
• Advanced breast cancer
• Polycythaemia vera - a disease which increases the number of red cells in
your blood. This makes the blood thicken and causes blood clots. This leads to
headaches, dizziness and shortness of breath
Ask your doctor if you would like more explanation about these diseases.

Originated on:
22 Mar 2017
Amended on:
N/A

2  Before you take Melphalan
Do not take Melphalan if:
• You are allergic (hypersensitive) to melphalan or any of the other ingredients of
Melphalan tablets (See section 6: Further information)
Do not take if the above applies to you. If you are not sure, talk to your doctor or
pharmacist before taking Melphalan.
Take special care with Melphalan
Before you take Melphalan, tell your doctor or pharmacist if:
• you have had radiotherapy or chemotherapy, now or recently
• you have a kidney problem.
If you are not sure if any of the above apply to you, talk to your doctor or
pharmacist before taking Melphalan.
Taking other medicines

PHARMA CODE N° 3141

Please tell your doctor or pharmacist if you are taking or have recently taken any
other medicines, including medicines obtained without a prescription. This includes
herbal medicines.
In particular, you must tell your doctor if you are taking any of the following:
• other cytotoxic drugs (chemotherapy)
• nalidixic acid (an antibiotic used to treat urinary tract infections)
• ciclosporin (used to prevent rejection of organs or tissues following a transplant
or to treat certain skin conditions like psoriasis and eczema or to treat
rheumatoid arthritis).
Having vaccines while you are taking Melphalan
If you are going to have a vaccination speak to your doctor or nurse before you
have it. This is because some vaccines (like polio, measles, mumps and rubella) may
give you an infection if you have them whilst you are taking Melphalan.
Pregnancy and breast-feeding
Do not take Melphalan if you are planning to have a baby. This applies to both
men and women. Melphalan may harm your sperm or eggs. Reliable contraceptive
precautions must be taken to avoid pregnancy whilst you or your partner is taking
these tablets. Ask your doctor for advice.
If you are already pregnant, it is important to talk to your doctor before taking
Melphalan.
Do not breast-feed while taking Melphalan. Ask your doctor or midwife for advice.

The dose of Melphalan depends on your blood problem or cancer (see section 1).
• Your doctor may also change your dose during your treatment, depending on
your needs.
• The dose can sometimes be changed if you are elderly or have a kidney problem.
• When you take Melphalan, your doctor will take regular blood tests. This is to
check the number of cells in your blood. Your doctor may sometimes change your
dose as a result.
Multiple myeloma
• The usual dose is 0.15 mg per kilogram of your body weight each day for 4 days.
This is repeated every 6 weeks.
Advanced ovarian adenocarcinoma
• The usual dose is 0.2 mg per kilogram of your body weight each day for 5 days.
This is repeated every 4 to 8 weeks.
Advanced breast carcinoma
• The usual dose is 0.15 mg per kilogram of your body weight each day for 5 days.
This is repeated every 6 weeks.
Polycythaemia vera
• Initially 6 to 10 mg each day for 5 to 7 days. The dose will then be reduced to
2 to 4 mg each day.
If you take more Melphalan than you should
If you take more Melphalan than you should, tell your doctor immediately or go to
a hospital straight away. Take the medicine pack with you.
If you forget to take Melphalan
Tell your doctor. Do not take a double dose to make up for a forgotten dose.
4  Possible side effects
Like all medicines, Melphalan can cause side effects, although not everybody gets
them.
If you get any of the following, talk to your specialist doctor or go to hospital
straight away:
• allergic reaction, the signs may include:
-- a rash, lumps or hives on the skin
-- swollen face, eyelids or lips
-- sudden wheeziness and tightness of the chest
-- collapse (due to cardiac arrest)
• any signs of fever or infection (sore throat, sore mouth or urinary problems)
• any unexpected bruising or bleeding or feeling extremely tired, dizzy or
breathless, as this could mean that too few blood cells of a particular type are
being produced
• if you suddenly feel unwell (even with a normal temperature).
Talk to your doctor if you have any of the following side effects which may also
happen with this medicine:
Very common (affects more than 1 in 10 people)
• a drop in the number of blood cells and platelets
• feeling sick (nausea), being sick (vomiting) and diarrhoea
• mouth ulcers - with high doses of Melphalan
• hair loss - with high doses of Melphalan
Common (affects less than 1 in 10 people)
• hair loss - with usual doses of Melphalan
• high levels of a chemical called urea in your blood - in people with kidney
problems who are being treated for myeloma

PHARMA CODE N° 3141

Always take Melphalan exactly as your doctor has told you. It is important to take
your medicine at the right times. The label on your pack will tell you how many
tablets to take and how often to take them. If the label doesn’t say or if you are not
sure, ask your doctor, nurse or pharmacist.
• Swallow your tablets whole with a glass of water.
• Do not break, crush or chew the tablets.

ASPEN Artwork Panel • May 2013 • Version 5

Drawing Version:
01

1  What Melphalan is and what it is used for

Melphalan should only be given to you by a specialist doctor who is experienced in
treating blood problems or cancer.

160 mm Measuring Bar

Product Name:
Alkeran

In this leaflet:
1 What Melphalan is and what it is used for
2 Before you take Melphalan
3 How to take Melphalan
4 Possible side effects
5 How to store Melphalan
6 Further information

3  How to take Melphalan

Page:
1 of 2

ASPEN Artwork Panel
Page:
2 of 2

New Item Code:
7000183-1001
Replacement:
7212466-6758
Market:
United Kingdom
Product Name:
Alkeran
Number of Colours:
1
BLACK

5  How to store Melphalan
• Keep out of the reach and sight of children.
• Do not use Melphalan after the expiry date, which is stated on the pack after
‘Exp’.
• Store in a refrigerator between 2 and 8°C.
• If your doctor tells you to stop taking the tablets, it is important to return any
which are left over to your pharmacist, who will destroy them according to
disposal of dangerous substance guidelines. Only keep the tablets if your doctor
tells you to.
6  Further information
What Melphalan contains
The active ingredient is melphalan. Each Melphalan tablet contains 2 mg of
melphalan. The other ingredients are microcrystalline cellulose, crospovidone,
colloidal anhydrous silica, magnesium stearate, hypromellose, titanium dioxide and
macrogol.
What Melphalan looks like and contents of the pack
Melphalan tablets are white to off-white film-coated, round, biconvex tablets
engraved with ‘GX EH3’ on one side and ‘A’ on the other. Your Melphalan tablets are
in bottles of 25 tablets.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation holder:
Aspen Pharma Trading Limited
3016 Lake Drive,
Citywest Business Campus,
Dublin 24, Ireland.
Service-Tel: 0800 008 7392 (+ 44 1748 828 391)
Manufacturer: EXCELLA GmbH & Co. KG, Nürnberger Strasse 12, 90537 Feucht,
Germany
Other formats:
To listen to or request a copy of this leaflet in Braille, large print or audio please call,
free of charge:
0800 198 5000 (UK only).
Please be ready to give the following information:
Product name: Melphalan 2 mg tablets
Reference number: PL 39699/ 0043
This is a service provided by the Royal National Institute of Blind People.
Leaflet date: 01/2017

7000183-1001

Manufacturing Site:
Excella

160 mm Measuring Bar

If any of the side effects gets serious, or if you notice any side effects not listed in
this leaflet, please tell your doctor or pharmacist.

AW Version:
1

Drawing Ref. Number:
148 x 630 folded Plano V02
Drawing Version:
01
Originated by:
Alanna Clinton
Originated at:
APTL
Originated on:
22 Mar 2017
Amended on:
N/A

ASPEN Artwork Panel • May 2013 • Version 5

Rare (affects less than 1 in 1,000 people)
• an illness where you have a low number of red blood cells as they are being
destroyed prematurely - this can make you feel very tired, breathless and dizzy
and can give you headaches or make your skin or eyes yellow
• lung problems which may make you cough or wheeze and make it difficult to
breathe
• liver problems which may show up in your blood tests or cause jaundice
(yellowing of the whites of eyes and skin)
• mouth ulcers - with normal doses of Melphalan
• skin rashes or itching skin
The following side effects also happen with Melphalan:
• leukaemia - cancer of the blood
• in women: your periods stopping

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide